šŸ“° Citrini added DRV to its model portfolio, with a target weight of around 10%. That’s eye-catching news, but let’s be clear: a target allocation in a model portfolio doesn’t mean it has already bought that much.
šŸ”„ The opportunity it sees is easy to understand: RWA could bring more assets on-chain, while AI agents may drive demand for automated trading and hedging. Derive offers options and perpetuals, and could earn ongoing fees from trading and risk management. But whether that demand actually materializes depends on real-world usage.

To be fair, Derive’s achievements and its gaps are both pretty clear. In Q3 2026, it accounted for about 90.4% of on-chain options premium trading volume. But among the major platforms listed in the source, its share of options open interest was only around 3.1%, and Deribit was still about 25 times its size. Its on-chain share is strong, but it still has a way to go in the broader market.

šŸ’” What I care more about is how much buybacks can support the token. The protocol uses 35% of its revenue to buy back DRV. Annualizing its revenue over the 30 days through October 10 gives an estimated buyback budget of about $2.41 million—just around 0.6% of the circulating market cap cited in the source. Having a buyback mechanism and having buybacks with meaningful impact are two different things.
šŸ¤” In any case, I’d look at the protocol’s business and token supply together: can fee revenue keep growing, and can buybacks offset new token issuance? When you assess DRV, would you put more weight on its 90.4% on-chain share or its roughly 0.6% theoretical annualized buyback ratio?

#DRV #Derive #é“¾äøŠč”ē”Ÿå“ #RWA